Novartis Institutes for BioMedical Research, Inc.

Sociétés où Novartis Institutes for BioMedical Research, Inc. a négocié

• Intellia Therapeutics, Inc.12 tx · $32.9M · Feb 14, 2019
• Surface Oncology, Inc.5 tx · $11.5M · Apr 23, 2018

Historique de performance de Novartis Institutes for BioMedical Research, Inc.

Historique insuffisant pour un historique de performance statistique (moins de 5 achats sur le marché).

Historique des transactions de Novartis Institutes for BioMedical Research, Inc.

Co-initiés de Novartis Institutes for BioMedical Research, Inc.

• NOVARTIS AGIntellia Therapeutics, Inc. +2
• Atlas Venture Associates IX, LLCIntellia Therapeutics, Inc. +1
• Atlas Venture Associates IX, L.P.Intellia Therapeutics, Inc. +1
• Atlas Venture Fund IX, L.P.Intellia Therapeutics, Inc. +1
• Fullerton Management Pte LtdIntellia Therapeutics, Inc. +1
• GRAYZEL DAVID S.Q32 Bio Inc. +1
• ORBIMED ADVISORS LLCIntellia Therapeutics, Inc. +1
• TEMASEK HOLDINGS (PRIVATE) LTDIntellia Therapeutics, Inc. +1
• Temasek Life Sciences Private LTDIntellia Therapeutics, Inc. +1
• TLS Beta Pte. Ltd.Intellia Therapeutics, Inc. +1
• 5AM Co-Investors IV, L.P.Q32 Bio Inc.
• 5AM Partners IV, LLCQ32 Bio Inc.
• 5AM Ventures IV, L.P.Q32 Bio Inc.
• Adams ChandraSurface Oncology, Inc.
• Alloway PaulQ32 Bio Inc.
• ARCH Venture Fund VIII, L.P.Q32 Bio Inc.